HPLC determination of andrographolide in rat whole blood: Study on the pharmacokinetics of andrographolide incorporated in liposomes and tablets

Biomedical Chromatography

Volumn 21, Issue 7, 2007, Pages 730-734

  Suo, Xu Bin ^a   Zhang, Han ^b   Wang, Yu Qiang ^a  

^a JINAN UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Andrographolide; HPLC; Liposomes; Pharmacokinetics; Tablets

Indexed keywords

BLOOD; CHLORINE COMPOUNDS; CHROMATOGRAPHIC ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHARMACOKINETICS; RATS;

ANDROGRAPHOLIDE; BLOOD SAMPLES; CARBAMAZEPINE; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHIC METHODS; HPLC; INTERNAL STANDARDS; RAT WHOLE BLOOD; SIMPLE++; TABLET; UV DETECTION;

LIPOSOMES;

ANDROGRAPHOLIDE; CARBAMAZEPINE; CHLOROFORM; LIPOSOME; METHANOL; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CHROMATOGRAPHY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG DISPOSITION; DRUG HALF LIFE; DRUG RETENTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RAT; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; SPRAGUE DAWLEY RAT; TABLET; TIME TO MAXIMUM PLASMA CONCENTRATION; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

RATTUS;

EID: 34447530213     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.812     Document Type: Article

References (8)

1. Amroyan E, Gabrielian E, Panossian A, Wikman G and Wagnar H. Inhibitory effect of andrographolide from andrographis paniculata on PAF-induced platelet aggregation. Phytomedicine 1999; 6: 27-31.
2. Calabrese C, Berman SH, Babish JG, Ma XF, Shinto L, Dorr M, Wells K, Wenner CA and Standish LJ. A phase I trial of andrographolide in HIV positive patients and normal volunteers. Phytotherapy Research 2000; 14: 333-338.
3. Handa SS and Sharma A. Hepatoprotective activity of andrographolide from andrographis paniculata against carbontetrachloride, Indian Journal Medical Research 1990; 92: 276-283.
4. Hidalgo MA, Romero A, Figueroa J, Cortes P, Concha HI, Hancke JL and Burgos RA. Andrographolide interferes with binding of nuclear factor- κB to DNA in HL-60-derived neutrophilic cells. British Journal Pharmacology 2005; 144: 680-686.
5. Iruretagoyena MI, Tobar JA, Gonzalez PA, Sepulveda SE, Figueroa CA, Burgos RA, Hancke JL and Kalergis AM. Andrographolide interferes with T cell activation and reduces experimental autoimmune encephalomyelitis in the mouse. The Journal of Pharmacology and Experimental Therapeutics 2005; 312: 366-372.
6. Panossian A, Hovhannisyan A, Mamikonyan G, Abrahamian H and Hambardzumyan E. Pharmacokinetic and oral bioavailability of andrographolide from Andrographis paniculata fixed combination Kan Jang in rats and human. Phytomedicine 2000; 7(5): 351-364.
7. Sinha J, Mukhopadhyay S, Das N and Basu MK. Targeting of liposomal andrographolide to L.donovani-infected macrophages in vivo. Drug Delivery 2000; 7(4): 209-213.
8. Tsai HR, Yang LM, Tsai WJ and Chiou WF. Andrographolide acts through inhibition of EPK1/2 and Akt Phosphorylation to suppress chemotactic migration. European Journal of Pharmacology 2004; 498: 45-52.